Followers | 520 |
Posts | 40228 |
Boards Moderated | 21 |
Alias Born | 09/16/2007 |
Friday, April 01, 2011 4:25:42 PM
Agic Convertible & Income Fund Ii (NYSE:NCZ)
Intraday Stock Chart
Today : Friday 1 April 2011
Click Here for more Agic Convertible & Income Fund Ii Charts.
The Boards of Trustees of AGIC Convertible & Income Fund (NYSE: NCV) and AGIC Convertible & Income Fund II (NYSE: NCZ) (collectively, the “Funds”) announced today that they have declared the following dividends on the Funds’ common shares:
AGIC Convertible & Income Fund
$0.09
per common share
AGIC Convertible & Income Fund II
$0.085
per common share
The dividends will be payable on May 2, 2011 to shareholders of record on April 11, 2011, with an ex-dividend date of April 7, 2011.
At March 31, 2011, the Funds’ net assets (a) were approximately:
(in millions)
AGIC Convertible & Income Fund $ 1,076.3
AGIC Convertible & Income Fund II $ 816.8
(a) Net assets are inclusive of Preferred Shares of $357 million and $274 million for NCV and NCZ, respectively.
The Funds are closed-end management investment companies. The Funds’ investment objective is to provide total return through a combination of capital appreciation and high current income. There can be no assurance that the Funds will achieve their stated objectives.
Allianz Global Investors Fund Management LLC (“AGIFM”), an indirect, wholly-owned subsidiary of Allianz Global Investors of America L.P., serves as the Funds’ investment manager and is a member of Munich-based Allianz Group. Allianz Global Investors Capital LLC, an AGIFM affiliate, serves as the Funds’ sub-adviser.
The Funds’ daily New York Stock Exchange closing prices, net asset values per share, as well as other information, including updated portfolio statistics and performance is available at www.allianzinvestors.com or by calling the Funds’ shareholder servicing agent at (800) 254-5197.
Statements made in this release that look forward in time involve risks and uncertainties and are forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such risks and uncertainties include, without limitation, the adverse effect from a decline in the securities markets or a decline in the Funds’ performance, a general downturn in the economy, competition from other companies, changes in government policy or regulation, inability to attract or retain key employees, inability to implement its operating strategy and/or acquisition strategy, and unforeseen costs and other effects related to legal proceedings or investigations of governmental and self-regulatory organizations. The Funds’ ability to pay dividends to common shareholders is subject to the restrictions in their registration statements, by-laws and other governing documents, as well as the Investment Company Act of 1940.
Recent NCZ News
- Virtus Convertible & Income Fund II Announces Quarterly Distribution: 5.500% Series A Cumulative Preferred Shares • Business Wire • 09/03/2024 08:20:00 PM
- Two Virtus Closed-End Funds Announce Two Monthly Distributions: NCV, NCZ • Business Wire • 08/29/2024 08:35:00 PM
- Two Virtus Closed-End Funds Announce Two Monthly Distributions: NCV, NCZ • Business Wire • 06/06/2024 08:45:00 PM
- Virtus Closed-End Funds Announce Results of Joint Annual Meeting of Shareholders • Business Wire • 06/04/2024 01:00:00 PM
- Virtus Convertible & Income Fund II Announces Quarterly Distribution: 5.500% Series A Cumulative Preferred Shares • Business Wire • 06/03/2024 08:20:00 PM
- Virtus Convertible & Income Fund II Announces Quarterly Distribution: 5.500% Series A Cumulative Preferred Shares • Business Wire • 03/01/2024 01:15:00 PM
- Two Virtus Closed-End Funds Announce Four Monthly Distributions: NCV, NCZ • Business Wire • 03/01/2024 01:15:00 PM
- Virtus Convertible & Income Fund II Announces Quarterly Distribution: 5.500% Series A Cumulative Preferred Shares • Business Wire • 12/01/2023 01:45:00 PM
- Certain Virtus Closed-End Funds Announce Three Monthly Distributions: NCV, NCZ, CBH • Business Wire • 11/16/2023 10:45:00 PM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM